A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome

Bone Marrow Transplantation, Published online: 27 March 2024; doi:10.1038/s41409-023-02195-xA phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome

https://www.nature.com/articles/s41409-023-02195-x

Source: Bone Marrow Transplantation - March 27, 2024 Category: Hematology Authors: Ray Mun Koo Eric Wong Joanne E. Davis Travis Perera Andrew Lim Rachel M. Koldej David S. Ritchie Source Type: research